Stocks of the Hour: Lincoln Minerals, OncoSil Medical, Avira Resources
A snapshot of the stocks on the move, featuring Lincoln Minerals (ASX:LML), OncoSil Medical (ASX:OSL) and Avira Resources (ASX:AVW).
Watch Now
Oncosil Medical Ltd
OncoSil Medical is a medical device company seeking to advance radiation for cancer patients. OncoSil Medical’s lead product, OncoSilTM is a targeted radioactive isotope (Phosphorus-32), implanted directly into a patient’s pancreatic tumours via an endoscopic ultrasound. Treatment with the OncoSilTM is intended to deliver more concentrated and localised beta radiation compared to external beam radiation.
OncoSil Medical has conducted six clinical studies with positive results on tolerability, safety and efficacy. CE Marking has been granted for the OncoSilTM device which can be marketed in the European Union and the United Kingdom. The OncoSilTM device has also been classified a Breakthrough Device in the European Union and the United Kingdom.
Spotlight Videos
OncoSil Medical (ASX: OSL) – Targeted therapy for pancreatic cancer
OncoSil Medical Limited Non-Executive Director Brian Leedman discusses joining the board of OncoSil and receiving CE mark approval for the company's therapy.
Watch Now
Oncosil Medical – ShareCafe Hidden Gems Webinar Presentation
Presenter – Daniel Kenny - CEO - OncoSil Medical is a medical device company seeking to advance radiation for cancer patients. OncoSil Medical’s lead product, OncoSilTM is a targeted radioactive isotope (Phosphorus-32), implanted directly into a patient’s pancreatic tumours via an endoscopic ultrasound. Treatment with the OncoSilTM is intended to deliver more concentrated and localised beta radiation compared to external beam radiation.
Watch Now
